IL-7 Enhances Survival of Human CD56bright NK Cells
Authors:
- Emily CharrierECEmily Charrier
- Sabine HerblotSHSabine Herblot
- Michel DuvalMDMichel Duval
- 1 May 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 33 (4) , 382-390
Abstract
Lymphoid differentiation and activation critically depend on cytokine stimulation and the interleukin-7 (IL-7) signaling in particular. Although it has been demonstrated that IL-7 may play a role in natural killer (NK) cell maturation, the effect of IL-7 stimulation on mature human NK cells has not been studied. We, therefore, investigated the expression and functional activity of IL-7Rα on mature NK populations from adult blood. In this article, we demonstrate that IL-7Rα is specifically expressed in the CD56bright noncytotoxic cytokine-producing NK subset. Importantly, this expression is thymus independent, contrary to what is observed in mice. In addition, we show that IL-7Rα is expressed at higher levels on NKG2A+CD56bright NK cells. In contrast to IL-15 stimulation, IL-7 does not increase NK cell cytotoxicity, interferon-γ production, or the expression of activation markers, indicating that these cytokines play different functions in NK homeostasis and activation. However, IL-7 promotes the survival of the CD56bright NK subset and inhibits apoptosis by increasing BCL2 expression. These data should be taken into account when considering the clinical use of IL-7, particularly after stem cell transplantation.Keywords
This publication has 34 references indexed in Scilit:
- Natural killer cell‐based immunotherapy in cancer: current insights and future prospectsJournal of Internal Medicine, 2009
- Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemiasImmunological Reviews, 2008
- Human natural killer cellsBlood, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- NK cell alloreactivity and allogeneic hematopoietic stem cell transplantationBlood Cells, Molecules, and Diseases, 2008
- Natural killer cells and dendritic cells: rendezvous in abused tissuesNature Reviews Immunology, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I moleculesEuropean Journal of Immunology, 1997
- NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.Journal of Experimental Medicine, 1994